amylin glp 1 dual agonist Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity Amylin Receptor Agonist - an
Description
Basic and Clinical Pharmacology and Toxicology
The cornerstone of safe GLP-1 therapy is open communication with your healthcare team
[DOI] [PubMed] [Google Scholar] 247.Onishi Y., et al
Common and Rare Side Effects When considering Zepbound, understanding potential side effects is crucial
Additionally, gastrointestinal side effects, such as nausea, vomiting, and diarrhea, are commonly associated with GLP-1 receptor agonists, especially during the initial phase of treatment
23 , e13435 (2022)
